Calamos Advisors’s Red Violet RDVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.55M Buy
40,005
+32,142
+409% +$1.52M 0.01% 632
2026
Q1
$272K Sell
7,863
-72,901
-90% -$3.21M ﹤0.01% 1061
2025
Q4
$4.6M Buy
80,764
+8,661
+12% +$470K 0.02% 546
2025
Q3
$3.77M Buy
72,103
+30,338
+73% +$1.44M 0.01% 575
2025
Q2
$2.05M Buy
41,765
+5,162
+14% +$225K 0.01% 629
2025
Q1
$1.38M Buy
36,603
+20,970
+134% +$790K 0.01% 623
2024
Q4
$566K Buy
+15,633
New +$521K ﹤0.01% 714

Other funds holding RDVT

Calamos Advisors's RDVT Position: Q2 2026 in Review

Calamos Advisors increased its Red Violet (RDVT) stake by 409% in Q2 2026, buying an estimated $1.52M and bringing the position to 40,005 shares worth $2.55M. The position accounts for 0.01% of the portfolio, ranked #632.

Calamos Advisors first reported a position in RDVT in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.6M in Q4 2025. 173 funds tracked by Wall St. Rank hold RDVT as of Q2 2026.

  • Calamos Advisors held 40,005 shares of Red Violet worth $2.55M as of Q2 2026.
  • Calamos Advisors bought 32,142 Red Violet shares in Q2 2026, an estimated $1.52M.
  • Red Violet made up 0.01% of Calamos Advisors's portfolio in Q2 2026, its #632 holding.
  • Calamos Advisors first reported a position in Red Violet in Q4 2024 and has held it in 7 quarters since.
  • Calamos Advisors's Red Violet position peaked at $4.6M in Q4 2025.
  • 173 funds tracked by Wall St. Rank held Red Violet as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.